You are viewing an incomplete version of our website. Please click to reload the website as full version.

Navigieren Sie durch unsere anti-BCL2L1 (BCL2L1) Antikörper

Full name:
anti-BCL2-Like 1 Antikörper (BCL2L1)
Auf finden Sie aktuell 517 BCL2-Like 1 (BCL2L1) Antikörper von 35 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen BCL2L1 Kits (20) und BCL2L1 Proteine (20) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 580 BCL2L1 Produkte verfügbar.
Bcl(X)L, bcl-X, bcl-x(l), bcl-xl, BCL-XL/S, Bcl-Xs, Bcl2l, BCL2L1, Bclx, BCLXL, BCLXS, PPP1R52, xR11
Alle Antikörper anzeigen Gen GeneID UniProt
BCL2L1 60480  
BCL2L1 598 Q07817
BCL2L1 24888 P53563

Alle Spezies anzeigen

Weitere Synonyme anzeigen

Alle verfügbaren anti-BCL2L1 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-BCL2L1 Antikörper

  1. Human Monoclonal BCL2L1 Primary Antibody für IF, IP - ABIN968152 : Anderson, Teutsch, Dong, Wortis: An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis. in Proceedings of the National Academy of Sciences of the United States of America 1996 (PubMed)
    Zeige alle 5 Referenzen für ABIN968152

  2. Human Monoclonal BCL2L1 Primary Antibody für WB - ABIN967300 : Hsu, Wolter, Youle: Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. in Proceedings of the National Academy of Sciences of the United States of America 1997 (PubMed)
    Zeige alle 4 Referenzen für ABIN967300

  3. Human Polyclonal BCL2L1 Primary Antibody für IHC, ELISA - ABIN1532818 : Cheng, Levine, Boise, Thompson, Hardwick: Bax-independent inhibition of apoptosis by Bcl-XL. in Nature 1996 (PubMed)
    Zeige alle 3 Referenzen für ABIN1532818

  4. Human Polyclonal BCL2L1 Primary Antibody für IP, WB - ABIN223050 : Cordiali-Fei, Ardigo, Mastroianni, Giuliani, D Agosto, Bordignon, Trento, Vento, Berardesca: Serum cytokines and biohumoral immunological characterization of psoriatic patients in long term etanercept treatment. in International journal of immunopathology and pharmacology 2008 (PubMed)
    Zeige alle 3 Referenzen für ABIN223050

  5. Human Polyclonal BCL2L1 Primary Antibody für IHC, ELISA - ABIN1531788 : Sattler, Liang, Nettesheim, Meadows, Harlan, Eberstadt, Yoon, Shuker, Chang, Minn, Thompson, Fesik: Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. in Science (New York, N.Y.) 1997 (PubMed)
    Zeige alle 3 Referenzen für ABIN1531788

  6. Human Monoclonal BCL2L1 Primary Antibody für FACS, IF - ABIN180627 : Hsu, Youle: Nonionic detergents induce dimerization among members of the Bcl-2 family. in The Journal of biological chemistry 1997 (PubMed)
    Zeige alle 3 Referenzen für ABIN180627

  7. Human Polyclonal BCL2L1 Primary Antibody für IHC, ELISA - ABIN1532107 : Boise, González-García, Postema, Ding, Lindsten, Turka, Mao, Nuñez, Thompson: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. in Cell 1993 (PubMed)
    Zeige alle 2 Referenzen für ABIN1532107

  8. Human Polyclonal BCL2L1 Primary Antibody für IHC, ELISA - ABIN1533140 : Deloukas, Matthews, Ashurst, Burton, Gilbert, Jones, Stavrides, Almeida, Babbage, Bagguley, Bailey, Barlow, Bates, Beard, Beare, Beasley, Bird, Blakey, Bridgeman, Brown, Buck, Burrill, Butler, Carder et al.: The DNA sequence and comparative analysis of human chromosome 20. ... in Nature 2002 (PubMed)
    Zeige alle 2 Referenzen für ABIN1533140

  9. Cow (Bovine) Polyclonal BCL2L1 Primary Antibody für WB - ABIN2779336 : ONeill, Manion, Maguire, Hockenbery: BCL-XL dimerization by three-dimensional domain swapping. in Journal of molecular biology 2006 (PubMed)

  10. Cow (Bovine) Polyclonal BCL2L1 Primary Antibody für WB - ABIN2774598 : Bachelor, Bowden: Ultraviolet A-induced modulation of Bcl-XL by p38 MAPK in human keratinocytes: post-transcriptional regulation through the 3'-untranslated region. in The Journal of biological chemistry 2004 (PubMed)

Weitere Antikörper gegen BCL2L1 Interaktionspartner

Mouse (Murine) BCL2-Like 1 (BCL2L1) Interaktionspartner

  1. MLF1 (zeige MLF1 Antikörper) is negatively regulated by 14-3-3 (zeige YWHAQ Antikörper) via binding to, and blocking, MLF1 (zeige MLF1 Antikörper)'s Bcl-2 (zeige BCL2 Antikörper) homology domain 3 and thereby preventing Bcl-XL from associating with MLF1 (zeige MLF1 Antikörper).

  2. Genetic and pharmacological inhibition of BCL-W (zeige BCL2L2 Antikörper) and BCL-XL causes directed elimination of senescent cells.

  3. Valproic acid sensitized TRAIL-resistant papillary thyroid carcinoma cells to apoptotic cell death through involvement of Nrf2 (zeige NFE2L2 Antikörper) and Bcl-xL.

  4. The influence of chronic ethanol consumption on the expression of the Bdnf (zeige BDNF Antikörper), Bax (zeige BAX Antikörper), Bcl-xL, and CASP3 (zeige CASP3 Antikörper) genes was studied in the brain structures of B6-1473C (C/C) and B6-1473G (G/G) mice that had been obtained on the base of the C57BL/6 strain.

  5. despite its role in Bax (zeige BAX Antikörper) inhibition, Bcl-xL also primes mitochondria to permeabilization and cytochrome c (zeige CYCS Antikörper) release.

  6. These findings indicate that eosinophil survival is largely regulated by betac chain-induced NF-kappaB (zeige NFKB1 Antikörper) activation and subsequent induction of Bcl-x

  7. these data indicate that beta-cell apoptosis is, in part, attributable to the modulation of 5'SS selection in the Bcl-x pre-mRNA by bioactive lipids modulated by iPLA2beta (zeige PLA2G6 Antikörper).

  8. only loss of both Bclx alleles markedly forestalled tumorigenesis, loss of a single Bim (zeige BCL2L11 Antikörper) allele overcame this blockade.

  9. analysis of the role of BCL-XL or MCL-1 (zeige MCL1 Antikörper) in the development and sustained growth of thymic lymphoma elicited by loss of p53 (zeige TP53 Antikörper) reveals that only MCL-1 (zeige MCL1 Antikörper) is critical

  10. cell death is C/EBP homologous protein (CHOP (zeige DDIT3 Antikörper))-dependent, connecting these events to the UPR. Thus plasma cell differentiation proceeds through a Bcl-xL-dependent intermediate.

Human BCL2-Like 1 (BCL2L1) Interaktionspartner

  1. We conclude that Bcl-x plays a role in regulation of HSC (zeige FUT1 Antikörper) apoptosis and modulation of Bcl-x alternative splicing may become a novel molecular therapy for liver fibrosis.

  2. Intracellular expression of Bcl-xL was significantly greater in CD4 (zeige CD4 Antikörper)+ T-cells, CD8 (zeige CD8A Antikörper)+ T-cells, and NK cells of infants with bronchiolitis compared to controls.

  3. Data indicate the potential of functionalized Apt-carbon nanotubes conjugates for increasing the induction of apoptosis in Mucin-1 (MUC1 (zeige MUC1 Antikörper)) positive tumor cells by suppression of Bcl-xL transcript.

  4. Co-administration of the mTORC1/TORC2 (zeige CRTC2 Antikörper) inhibitor INK128 and the Bcl-2 (zeige BCL2 Antikörper)/Bcl-xL antagonist ABT-737 kills human myeloid leukemia (zeige BCL11A Antikörper) cells through Mcl-1 (zeige MCL1 Antikörper) down-regulation and AKT (zeige AKT1 Antikörper) inactivation.

  5. Genetic and pharmacological inhibition of BCL-W (zeige BCL2L2 Antikörper) and BCL-XL causes directed elimination of senescent cells.

  6. Data suggest that regulation of Bax (zeige BAX Antikörper) stability and transport between cytosol and mitochondria is more tightly regulated by Bcl-xL/BCL2L1 when Bax (zeige BAX Antikörper) has been phosphorylated at Ser184 by AKT1 (zeige AKT1 Antikörper); experiments involved expression in haploid yeast strains.

  7. miR (zeige MLXIP Antikörper)-133a and miR (zeige MLXIP Antikörper)-326 downregulate the mRNA expression of Bcl-xl in HepG2 cells.

  8. Bcl-xL is a key factor in polyploidization resistance in acute myeloid leukemia (zeige BCL11A Antikörper)

  9. This study lends new molecular insights into understanding the binding specificity of BH3 ligands to BclXL with important consequences on the design of novel anticancer drugs.

  10. TCERG1 (zeige TCERG1 Antikörper) sensitizes a cell to apoptotic agents, thus promoting apoptosis by regulating the alternative splicing of both the Bcl-x and Fas/CD95 (zeige FAS Antikörper) genes.

Pig (Porcine) BCL2-Like 1 (BCL2L1) Interaktionspartner

  1. interleukin-6 (zeige IL6 Antikörper), endothelin ET-1 (zeige EDN1 Antikörper), and apoptotic Bak (zeige BAK1 Antikörper) and Bcl-XL genes have roles in small bowel transplantation, in a swine model of ischemia and reperfusion injury

  2. Bcl-xL was significantly decreased in haploid parthenotes compared with the diploid parthenotes. These results suggest that the haploid state affects apoptosis-related gene expression which results in increased apoptosis

  3. CONCLUSION(S): (1) Apoptosis is involved in follicular atresia; (2) Bcl-2 (zeige BCL2 Antikörper) is induced by warm ischemia; and (3) cryopreservation insult does not alter the apoptotic signals with short tissue preparation time.

  4. Bcl-Xl deamidation and methylation has a role in protein isoaspartate methyltransferase prevention of apoptosis induced by oxidative stress in endothelial cells

  5. Data show that cysteine significantly reduced the expression of pro-inflammatory cytokines, including TNF-alpha (zeige TNF Antikörper), IL-6 (zeige IL6 Antikörper), IL-12p40, IL-1beta (zeige IL1B Antikörper), and resulted in increased expression of the apoptosis initiator caspase-8 (zeige CASP8 Antikörper) and bcl2L1.

Cow (Bovine) BCL2-Like 1 (BCL2L1) Interaktionspartner

  1. amplification and characterization of partial regions of exons 2 and 3 of the bovine BCL2L1 gene

  2. Data show that Bcl-x(L) expression is increased in the pulmonary artery undergoing chronic pulmonary vascular remodeling.

Rabbit BCL2-Like 1 (BCL2L1) Interaktionspartner

  1. This study leads to conclude that BCLXL peak expression at the zygotic genome activation phase may be a requirement for embryo development

  2. In this study evidence is provided that exogenous PGF2alpha differentially modulates luteal expression of BCL2L1 transcripts and protein depending on luteal stage.

Xenopus laevis BCL2-Like 1 (BCL2L1) Interaktionspartner

  1. repression of radiation-induced apoptosis by overexpression of Bcl-xL during embryonic development depends upon the timing of its expression and post-translational events that enable the protein to become effective

BCL2L1 Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The proteins encoded by this gene are located at the outer mitochondrial membrane, and have been shown to regulate outer mitochondrial membrane channel (VDAC) opening. VDAC regulates mitochondrial membrane potential, and thus controls the production of reactive oxygen species and release of cytochrome C by mitochondria, both of which are the potent inducers of cell apoptosis. Two alternatively spliced transcript variants, which encode distinct isoforms, have been reported. The longer isoform acts as an apoptotic inhibitor and the shorter form acts as an apoptotic activator.

Alternative names and synonyms associated with BCL2L1

  • BCL2-like 1 (bcl2l1) Antikörper
  • BCL2-like 1 (BCL2L1) Antikörper
  • BCL2-like 1 (LOC100224900) Antikörper
  • transgene insertion 2, Craig B Thompson (Tg(BCL2L1)2Cbt) Antikörper
  • BCL2-like 1 (Bcl2l1) Antikörper
  • Bcl2-like 1 (Bcl2l1) Antikörper
  • Bcl(X)L Antikörper
  • bcl-X Antikörper
  • bcl-x(l) Antikörper
  • bcl-xl Antikörper
  • BCL-XL/S Antikörper
  • Bcl-Xs Antikörper
  • Bcl2l Antikörper
  • BCL2L1 Antikörper
  • Bclx Antikörper
  • BCLXL Antikörper
  • BCLXS Antikörper
  • PPP1R52 Antikörper
  • xR11 Antikörper

Bezeichner auf Proteinebene für anti-BCL2-Like 1 (BCL2L1) Antikörper

BCL2-like 1 , apoptosis regulator Bcl-X , bcl-2-like protein 1 , protein phosphatase 1, regulatory subunit 52 , B-cell leukemia/lymphoma x , anti-apoptosis regulatory protein , bcl2-L-1 , B cell lymphoma 2 like , B cell lymphoma like X , anti-apoptotic Bcl-xL , BCL2-like protein 1 , Bcl-X , BCLX protein , apoptosis regulator R11

447991 Xenopus (Silurana) tropicalis
458156 Pan troglodytes
100224900 Taeniopygia guttata
60480 Mus musculus
598 Homo sapiens
12048 Mus musculus
24888 Rattus norvegicus
397536 Sus scrofa
403618 Canis lupus familiaris
282152 Bos taurus
100008875 Oryctolagus cuniculus
493701 Felis catus
443061 Ovis aries
373954 Gallus gallus
398251 Xenopus laevis
Ausgewählte Anbieter für anti-BCL2L1 (BCL2L1) Antikörper
Haben Sie etwas anderes gesucht?